IQ

GNMX Corgi Genomics & Precision Medicine ETF

Share ▾
Share on XDownload as PDF
$38.11
+1.9% · 1 day, price
IQ’s readingComputed nightly from ETFIQ data. Not written live.

From its May 6, 2026 launch to Nov 4, 2026, GNMX returned 48.3%.

What drove GNMX’s returns?What can GNMX’s first months tell me?What does GNMX cost to hold and to trade?
Holds 57 stocks in genomics and gene editing, 31% of its weight in S&P 500 companiesCorgi ↗Expense ratio 0.35%Fund assets $1.3m on Nov 4, 2026First traded May 6, 2026Benchmark Its own holdings, as of Nov 4, 2026; its prospectus names no index it tracksSEC filings ↗Every Corgi fund ETFIQ covers

Promise check: Not measuredETFIQ has not yet listed which companies belong to the genomics and gene editing theme.

Compare with…Trading costsPut to the committeeaskIQ about GNMXAdd to portfolioOverlapFlowsAlerts

GNMX risk and return scorecard

vs its own holdings

Not measured: its benchmark is its own holdings, which has no weekly price series.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records; risk-free rate: U.S. Treasury, Daily Treasury Bill Rates, 13-week coupon equivalent Method · Data

Money in and out

Net fund flows · Jun 30, 2026
Since May 2026
+$1.3m
askIQ: what do these flows mean? ↗

What you earned

GNMX −2.8%: total return over one month to Nov 4, 2026.
GNMX−2.8%
GNMX +24.3%: total return over three months to Nov 4, 2026.
GNMX+24.3%
GNMX +48.3%: total return over six months to Nov 4, 2026.
GNMX+48.3%
GNMX +48.3%: total return since launch to Nov 4, 2026.
GNMX+48.3%
askIQ: what drove GNMX’s returns? ↗

What can be shown yet

First traded May 6, 2026
31.0%
Already in the S&P 500
Report
99.4%
Active share vs the S&P 500
Report
49.2%
Top ten holdings
Report
+48.3%
Total return, since launch
Report
GNMX has traded for 182 days. Numbers that need a year of prices are not shown yet.
Shown now
First tradedMay 6, 2026
Outside the S&P 500, by weight69%
Already in the Nasdaq-100, by weight7.7%
Active share vs the Nasdaq-10099.3%
Not yet
One-year returnfrom May 6, 2027
Three-year returnfrom May 6, 2029
askIQ: what can GNMX’s first months tell me? ↗

More on GNMX

Every number below is on this page. Open what you need.

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Price since launch, May 6, 2026

$38.11+1.9%1 day, priceClose, Nov 4, 2026

Price only. Computed by ETFIQ from Tiingo daily prices.

Source: Tiingo end-of-day prices. Data as of Nov 4, 2026. Updated every trading night. Report a data error

GNMX returns by window: total return, cash paid and price change
WindowTotal returnS&P 500 (SPY)
1M Oct 5 – Nov 4, 2026−2.8%−1.0%
3M Aug 5 – Nov 4, 2026+24.3%−0.1%
6M May 6 – Nov 4, 2026+48.3%+5.0%
Since launch May 6 – Nov 4, 2026+48.3%+5.0%

Total returns, distributions reinvested. Listed May 2026: no year to date, 1 year and 3 years windows.

Source: Tiingo end-of-day prices, with distributions reinvested.

Money in and out

Monthly data · as of Jun 30, 2026

GNMX: in the month to Jun 30, 2026, nothing net moved, by its SEC filing.

Since May 2026
+$1.3m
May 1, 2026 to Jun 30, 2026
monthly, from SEC filings

Computed by ETFIQ from the monthly sales and redemptions GNMX files with the SEC on Form N-PORT.

How this is computed

ETFIQ reads no daily data for this fund, so its flows are monthly, and the latest month filed is Jun 2026. Every day and month ETFIQ holds for GNMX, back to May 2026, is in its flows file. Flows across every fund · How these flows are computed · Compare GNMX with other funds in the flows tool

Month by month, money in and money outMay 2026 to Jun 2026

GNMX, money in and money out each month from May 2026 to Jun 2026: two bars a month, money in above the line and money out below. Every bar is from GNMX’s SEC filings (N-PORT item B.6). Of the 2 months listed, money came in on net in 1 and went out in 0.

Every bar is from GNMX’s SEC filings (N-PORT item B.6). Of the 2 months listed, money came in on net in 1 and went out in 0.

MonthInOutNet
Jun 2026 SEC Form N-PORT$0$0$0
May 2026 SEC Form N-PORT+$1.3m$0+$1.3m

Most recent first.

How this is computed

N-PORT months: money in is sales plus reinvestments; money out is redemptions.

N-PORT months are the filed sales plus reinvestments less redemptions. Later months add up the daily data; the Source column names any missing day.

Source: ETFIQ, from the fund’s SEC N-PORT filings. Data as of Jun 30, 2026. Updated when the fund files its next report.

GNMX key stats

High since May 6, 2026, daily closes to Nov 4, 2026 (ETFIQ)$39.77 on Oct 28, 2026
Low since May 6, 2026, daily closes to Nov 4, 2026 (ETFIQ)$24.05 on May 19, 2026
Close on Nov 4, 2026, within that range (ETFIQ)$38.11, 89% of the way from the low to the high
Holdings57
Top ten holdings weight49.2%
Range, beta and R-squared computed by ETFIQ from Tiingo daily prices.

Trading

as of Nov 4, 2026
Trading · GNMXas of Nov 4, 2026
·
Not scored2 of 6 measured · Nov 4, 2026
0 · Hard to tradeIQ Liquidity Score100 · Trades like a giant
Cost for your order · one way, half its 30-day median spread
Premium or discount to NAV, Nov 3 close+0.02%
−0.2%95% of days within ±0.13% · the 1% band is off this scale+0.2%
How to tradeSpread not read.
Full trading page: components, premium history, dealers →

GNMX for holders outside the US

US tax withheld on dividends, no treaty30%
Treaty rates on dividends (IRS table, read Oct 30, 2026)65 countries, 10% to 30%
GNMX interest-related and short-term gain dividendsnot read by ETFIQ
US estate tax filing threshold, non-resident holders$60,000
Share classDistributing

GNMX is a US fund. Stock of US corporations counts as US property for a non-resident's estate. Facts from the IRS, not tax advice. How withholding and treaties work
Download all holdings

GNMX top ten by weight, 49.2% of the fund, of its 57 equity positions, from the holdings published by its issuer for Nov 4, 2026. Source: the issuer’s own daily file.

Moderna Inc MRNA 11.24%
Thermo Fisher Scientific Inc TMO 8.88%
Vertex Pharmaceuticals Inc VRTX 6.04%
Genmab A/S GMAB 4.39%
Illumina Inc ILMN 3.92%
Guardant Health Inc GH 3.45%
Revolution Medicines Inc RVMD 3.24%
10X Genomics Inc TXG 2.87%
Incyte Corp INCY 2.70%
CareDx Inc CDNA 2.43%
Holdings, the issuer’s own daily file ↗See all 57 holdings →Check overlap with another fund →

Source: Corgi’s daily holdings file. Updated each trading day. Last checked Nov 4, 2026.

About GNMX

Theme (ETFIQ, editorial)Genomics and gene editing
First tradedMay 6, 2026
Already in the S&P 500, by weight (ETFIQ)31.0%
Outside the S&P 500, by weight (ETFIQ)69%
Active share vs the S&P 500 (ETFIQ)99.4%
Already in the Nasdaq-100, by weight (ETFIQ)7.7%
Active share vs the Nasdaq-100 (ETFIQ)99.3%
Top ten holdings weight49.2%
Holdings57
Holdings published for (the issuer’s daily file)Nov 4, 2026
Holdings as of the close of (the issuer’s daily file)Nov 4, 2026
Top holdingsModerna Inc 11.2%, Thermo Fisher Scientific Inc 8.9%, Vertex Pharmaceuticals Inc 6.0%, Genmab A/S 4.4%, Illumina Inc 3.9%, Guardant Health Inc 3.5%, Revolution Medicines Inc 3.2%, 10X Genomics Inc 2.9%, Incyte Corp 2.7%, CareDx Inc 2.4%
Net assets (the issuer’s own daily fund list, as of Nov 4, 2026)$1.3mReport
Benchmark (ETFIQ, from its filings)Its own holdings, as of Nov 4, 2026; its prospectus names no index it tracks
Below its all-time high (ETFIQ)−4.2%
Expense ratio (485BPOS XBRL, Apr 30, 2026)0.35%Report
Fee for the part that differs from the S&P 500, active expense ratio (ETFIQ)0.35%
Closest funds by holdings overlapGNOM 44%, IDNA 35%, HLTH 34%, ARKG 32%, IBB 31%
How we measure
Holdings from the file the issuer publishes daily; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. Method
IQ Investment Committee on GNMX

12 seats on GNMX, as of Nov 4, 2026: 1 Supports, 1 Mixed, 6 Challenges, 4 Not enough data.

In the tradition ofJohn BogleBogle-style Low CostChallenges
In the tradition ofBenjamin GrahamGraham-style Margin of SafetyChallenges
In the tradition ofWarren Buffett & Charlie MungerBuffett & Munger-style QualityNot enough data
In the tradition ofPeter LynchLynch-style Growth at a Reasonable PriceNot enough data
In the tradition ofJohn TempletonTempleton-style Global ContrarianNot enough data
In the tradition ofRay DalioDalio-style All-WeatherChallenges
In the tradition ofHoward MarksMarks-style Cycles & RiskChallenges
In the tradition ofStanley DruckenmillerDruckenmiller-style Macro & LiquidityChallenges
In the tradition ofDavid SwensenSwensen-style DiversificationChallenges
In the tradition ofCathie WoodWood-style Disruptive InnovationNot enough data
In the tradition ofJesse LivermoreLivermore-style Trend FollowingSupports
Uses ETFIQ’s measuresThe ETFIQ SkepticETFIQ’s own seatMixed
Put GNMX to the committee →See all seats →No investor named is affiliated with or endorses ETFIQ. Not investment advice.

Questions people ask about GNMX

How much of GNMX is in S&P 500 companies?
By its holdings published by its issuer for Nov 4, 2026, 31% of GNMX by weight is stocks the S&P 500 already holds. Its active share against the index is 99%, so that share is the part doing something different.
What does GNMX hold?
57 positions as published by its issuer for Nov 4, 2026, with the top ten at 49% of the fund. The largest are Moderna Inc at 11.2%, Thermo Fisher Scientific Inc at 8.9%, Vertex Pharmaceuticals Inc at 6.0%.
Has GNMX beaten the S&P 500?
Since it first traded on May 6, 2026, GNMX returned +48.3% with distributions reinvested, against +5.0% for the S&P 500, so it finished ahead of the index by 43.3 points.
What does GNMX cost?
The prospectus expense ratio is 0.35% a year. Because 99% of the fund differs from the S&P 500, the fee on that differing part works out at 0.35%.
Sources and dates
Prices, GNMX and S&P 500 (SPY)Tiingo end-of-day · Nov 4, 2026
Fee, 0.35%Prospectus filing with the expense ratio (SEC) ↗
Net assets, $1.3mThe issuer’s own daily fund list · Nov 4, 2026
HoldingsHoldings, the issuer’s own daily file · Nov 4, 2026 ↗
IssuerCorgi website ↗
All fund filingsFund filings on SEC EDGAR ↗

Links are sources, not endorsements.

Method →Standards and sources →Open data →
Cite this pageCitation, APA and Markdown

ETFIQ, GNMX, thematic ETFs, data as of Nov 4, 2026. https://etfiq.com/funds/gnmx

The difference bar for GNMX, redrawn every trading night.

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

Active share
How differently the money is placed, counting weights: one minus the sum of the smaller weight of each security across the fund and the index. 100% means nothing in common; 0% means the index itself. Two funds can hold the same names and still have a high active share if they weight them very differently.
Weight overlap
The share of money two portfolios hold in the same securities at the same weight.
Already in the index
The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at different weights.
Top ten
The weight of the ten largest holdings. Above 50% the fund is a bet on a handful of companies, whatever the theme.
Full definitions: thematic ETFs vocabulary page. →
Embed this chart

Free to use with the credit link. Paste this where the chart should go; it updates every trading night.

GNMX: 31% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.
<figure style="margin:0;max-width:640px">
<iframe src="https://etfiq.com/embed/themes/gnmx/" title="GNMX: 31% of GNMX&#x27;s weight is in S&amp;P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026." width="640" height="346" loading="lazy" style="border:0;max-width:100%;width:100%"></iframe>
<figcaption style="font:13px/1.5 sans-serif">GNMX: 31% of GNMX&#x27;s weight is in S&amp;P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026. Data: <a href="https://etfiq.com/funds/gnmx">ETFIQ</a></figcaption>
</figure>

How to embed ETFIQ charts

Get the ETFIQ Daily

The day's ETF flows, a comparison and one number. Every trading morning. About the Daily

The ETFIQ Daily and our other emails. Unsubscribe from any one in a click. See Privacy.

Snapshot, Nov 4, 2026. More on the tabs above.